Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2019;4(1):1666.DOI: 10.25107/2474-1663-v4-id1666

Case Report of Pathologically Confirmed Complete Response of Metastatic Breast Cancer after Long Term Experimental Antiangiogenic Treatment as Addition to Standard Therapeutic Approach

Mariani G, Galli G, Marchianò A , Regalia E , Gianni L and Valagussa P

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Italy Fondazione IRCCS Istituto Nazionale Tumori, Italy Department of Medical Oncology, San Raffaele Hospital Scientific Institute, Italy Fondazione Michelangelo, Italy

*Correspondance to: Mariani Gabriella 

 PDF  Full Text Case Report | Open Access

Abstract:

Metastatic breast cancer otherwise called stage IV or advanced breast cancer is one among the unspecific types of cancer and is most advanced. It spreads to lymph nodes and to other organs but still considered as breast cancer. Metastatic Breast Cancer (MBC) has remained an incurable disease so Complete Response (CR) in MBC is rare. However survival rates of patients with Metastatic Breast Cancer has gradually prolonged over the past few years due to improvement of Antineoplastic agents.

Keywords:

Metastatic breast cancer; Antiangiogenic treatment; Sorafenib

Cite the Article:

Mariani G, Galli G, Marchianò A, Regalia E, Gianni L, Valagussa P. GTV Cochlea Distance to Predict the Case Report of Pathologically Confirmed Complete Response of Metastatic Breast Cancer after Long Term Experimental Antiangiogenic Treatment as Addition to Standard Therapeutic Approach. Clin Oncol. 2019;4:1666.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Bovine Milk Derived Exosomal - Curcumin Exhibiting Enhanced Stability, Solubility, and Cellular Bioavailability
 Abstract  PDF  Full Text
First Successful Experience of Organ-Preserving Endoscopic Surgical Treatment for Upper Urinary Tract Urothelial Carcinoma
 Abstract  PDF  Full Text
View More...